Regeneron Pharmaceuticals Inc (REGN)
744.50
+1.15
(+0.15%)
USD |
NASDAQ |
Nov 21, 16:00
748.00
+3.50
(+0.47%)
After-Hours: 06:09
Regeneron Pharmaceuticals Total Liabilities (Quarterly): 8.116B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 8.116B |
| June 30, 2024 | 7.881B |
| March 31, 2024 | 7.378B |
| December 31, 2023 | 7.107B |
| September 30, 2023 | 7.259B |
| June 30, 2023 | 6.640B |
| March 31, 2023 | 6.565B |
| December 31, 2022 | 6.550B |
| September 30, 2022 | 6.239B |
| June 30, 2022 | 6.518B |
| March 31, 2022 | 6.434B |
| December 31, 2021 | 6.666B |
| September 30, 2021 | 6.414B |
| June 30, 2021 | 6.359B |
| March 31, 2021 | 5.795B |
| December 31, 2020 | 6.138B |
| September 30, 2020 | 5.958B |
| June 30, 2020 | 5.371B |
| March 31, 2020 | 3.624B |
| December 31, 2019 | 3.716B |
| September 30, 2019 | 3.435B |
| June 30, 2019 | 3.418B |
| March 31, 2019 | 3.410B |
| December 31, 2018 | 2.977B |
| September 30, 2018 | 2.937B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.766B |
| March 31, 2018 | 2.805B |
| December 31, 2017 | 2.620B |
| September 30, 2017 | 2.650B |
| June 30, 2017 | 2.586B |
| March 31, 2017 | 2.951B |
| December 31, 2016 | 2.524B |
| September 30, 2016 | 2.337B |
| June 30, 2016 | 2.128B |
| March 31, 2016 | 2.139B |
| December 31, 2015 | 1.954B |
| September 30, 2015 | 1.886B |
| June 30, 2015 | 1.189B |
| March 31, 2015 | 1.227B |
| December 31, 2014 | 1.287B |
| September 30, 2014 | 1.188B |
| June 30, 2014 | 1.087B |
| March 31, 2014 | 1.049B |
| December 31, 2013 | 998.94M |
| September 30, 2013 | 950.24M |
| June 30, 2013 | 884.92M |
| March 31, 2013 | 869.65M |
| December 31, 2012 | 835.10M |
| September 30, 2012 | 854.59M |
| June 30, 2012 | 862.84M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.624B
Minimum
Mar 2020
8.116B
Maximum
Sep 2024
6.336B
Average
6.476B
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 83.36B |
| Eli Lilly and Co | 61.29B |
| Pfizer Inc | 126.92B |
| Biogen Inc | 11.95B |
| AbbVie Inc | 137.35B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.44B |
| Shareholders Equity (Quarterly) | 29.33B |
| Debt to Equity Ratio | 0.0677 |
| Current Ratio | 5.281 |
| Net Debt Paydown Yield | -0.00% |